Abstract Body

Pre-exposure prophylaxis (PrEP) is a highly effective means for preventing HIV acquisition. However, use among young women has generally been suboptimal and poorly characterized. We present objectively measured adherence and associated socio-behavioral factors among a cohort of young women. 

Participants were 18-24 year old women at high risk for HIV in Thika and Kisumu, Kenya. High risk was defined as a VOICE risk score >4; points (pts) were given for age <25 (2 pts), being single or not living with a primary sexual partner (2 pts), lacking financial or material support from a sexual partner (1 pt), a sexual partner having or potentially having other partners (2 pts), and alcohol use (1 pt). Participants were encouraged to take PrEP for at least 6 months and then counseled on continued use based on their preferences and HIV risk. Study visits occurred at 1 month, 3 months, and then quarterly for 24 months. Adherence was measured with a real-time electronic monitor (Wisepill) and summarized descriptively. Baseline predictors of high adherence were assessed by multivariable logistic regression analysis. 

A total of 347 women have been followed for 461 person-years (as of June 2019; study to end early 2020). At 1, 3, and 6 months of desired PrEP use, 35%, 14%, and 7% of participants took an average of 6 doses per week, respectively, while 50%, 24%, and 15% took an average of 5 doses per week. The only baseline factor significantly associated with high adherence (an average of 6 doses per week) over 6 months was the VOICE risk score: OR 0.53 (95% CI 0.33, 0.85) for each additional point (figure). Non-significant factors included in the model were age, number of current sexual partners, concern about PrEP, prior medication use, and intimate partner violence. Findings were similar when high adherence was defined as an average of 5 doses per week.

Objectively measured PrEP adherence likely to be sufficient for protection against HIV was seen in a minority of participants and declined with time. Higher baseline HIV risk was associated with lower adherence in the first 6 months of use. These findings suggest limited prevention-effective adherence, although future analyses will assess the alignment of risk and adherence over time. Similar assessments in other PrEP cohorts may be useful for program evaluation; novel approaches are needed to help young women understand risk and the means to achieve effective HIV prevention.